Literature DB >> 16603436

Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea.

Yada Tingthanatikul1, Wicharn Choktanasiri, Mana Rochanawutanon, Sawaek Weerakeit.   

Abstract

The aim of the present study was to determine the prevalence and clinical predictors of endometrial hyperplasia (EH) in amenorrheic women with anovulation. Fifty-seven women were enrolled in the study. Of these, 43 were diagnosed to have polycystic ovary syndrome (PCOS) and 14 to have idiopathic anovulation. All women received transvaginal sonography to assess endometrial thickness (ET), patterns and abnormalities. At the same time, an endometrial biopsy was taken using a Pipelle instrument. The women's age, body mass index (BMI) and waist-to-hip ratio (WHR) were 32.0+/-6.0 years, 27.3+/-6.5 kg/m(2) and 0.82+/-0.06 (mean+/-standard deviation), respectively. Twenty (35.1%) and 19 (33.3%) women were classified as obese by BMI and WHR, respectively. Hypertension was found in 17 (29.8%) women. The prevalence of EH was 45.6%. Most cases were simple EH, and only one (1.75%) was simple EH with atypia. EH prevalence was 48.8% and 35.7% in PCOS and idiopathic anovulatory women, respectively. Age, BMI, WHR and ET did not predict EH, whereas the endometrial hyperechogenic pattern was a clinical predictor of EH with borderline significance. In conclusion, this study demonstrated that almost half of the anovulatory women with amenorrhea had EH and no significant predictor was found. In view of these findings, an endometrial biopsy should be performed in all women with this disorder.

Entities:  

Mesh:

Year:  2006        PMID: 16603436     DOI: 10.1080/09513590600585997

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  8 in total

1.  Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.

Authors:  A Villavicencio; A Goyeneche; C Telleria; K Bacallao; F Gabler; A Fuentes; M Vega
Journal:  Gynecol Oncol       Date:  2009-07-23       Impact factor: 5.482

2.  Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome.

Authors:  Abha Majumdar; Tejshree A Singh
Journal:  J Hum Reprod Sci       Date:  2009-01

3.  Metformin for endometrial hyperplasia: a Cochrane protocol.

Authors:  Naomi S Clement; Thomas R W Oliver; Hunain Shiwani; Juliane R F Saner; Caroline A Mulvaney; William Atiomo
Journal:  BMJ Open       Date:  2016-08-16       Impact factor: 2.692

Review 4.  Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk.

Authors:  Rosa Lauretta; Giulia Lanzolla; Patrizia Vici; Luciano Mariani; Costanzo Moretti; Marialuisa Appetecchia
Journal:  Int J Endocrinol       Date:  2016-09-20       Impact factor: 3.257

5.  Abnormal Uterine Bleeding- evaluation by Endometrial Aspiration.

Authors:  Pratibha Singh
Journal:  J Midlife Health       Date:  2018 Jan-Mar

Review 6.  Evaluation of intrauterine structural pathology by three-dimensional sonohysterography using an extended imaging method.

Authors:  Fatemeh Zafarani; Firoozeh Ahmadi
Journal:  Int J Fertil Steril       Date:  2013-03-06

7.  Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia.

Authors:  Fariba Ramezanali; Gholamreza Khalili; Arezoo Arabipoor; Narges Bagheri Lankarani; Ashraf Moini
Journal:  Int J Fertil Steril       Date:  2016-04-05

8.  The yield of endometrial aspiration in women with various risk factors and bleeding abnormalities.

Authors:  Anita L Nelson; Lisa Vasquez; Roya Tabatabai; Samuel S Im
Journal:  Contracept Reprod Med       Date:  2016-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.